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Abstract
AIM: This study aimed to determine the relationship between CTS, metabolic syndrome and obesity and to compare 
the severity of CTS between patients with or without metabolic syndrome (MS) and patients with or without obesity.
METHODS: In this prospective study, patients with clinical and electrophysiological confirmed diagnosis of CTS were 
included. The waist circumference, blood pressure, fasting blood glucose, fasting triglycerides and high/low density 
lipoprotein cholesterol levels were recorded. Patients were categorized having metabolic syndrome according to 
Adult Treatment Panel III definition, while body mass index was used to identify obesity.
RESULTS: A total of 65 patients with a mean age of 58.91 ± 12.49 years were included. MS was found in 39 (60%) 
patients and obesity in 27 (41.5%) patients. The CTS was described as mild, moderate and severe in 8, 12 and 19 
hands of those with MS and in 2, 6, and 18 of those without MS respectively (p = 0.207). There were no statistically 
significant results observed between BMI and the severity of CTS (p > 0.05). The mean waist circumference was 
94.75 ± 7.36, 98.78 ± 9.64, 106.42 ± 10.78, 86.41 ± 6.77 for patients with MS+O–, MS–O+, MS+O+ and MS–O– 
respectively (p < 0.002). 
CONCLUSION: CTS appears to be more severe in patients with MS than in patients with obesity. Central obesity is 
one of the well-known risk factors for CTS, but components of MS may have a greater effect on the severity of CTS.
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Background
Carpal tunnel syndrome (CTS) is the most 
common upper limb entrapment neuropathy, which 
ranges from 2.7% to 5.8% in the general population [1]. 
CTS is more common in women with a male-to-female 
ratio between 1:3.1 and 1:10.1 [2]. Although its exact 
cause and pathogenesis are unclear, it is commonly 
associated with several conditions, such as obesity, 
hypothyroidism, diabetes mellitus, amyloidosis, 
and pregnancy [3], [4]. The metabolic syndrome 
(MS) is referred to the cooccurrence of several 
known cardiovascular risk factors, including insulin 
resistance, central obesity, atherogenic dyslipidemia, 
and hypertension [3]. The first definition attempt 
was made in 1999 by the World Health Organization 
(WHO), which proposed that MS may be defined by 
the presence of insulin resistance or its surrogates. 
In 2001, the National Cholesterol Education Program 
Adult Treatment Panel III (NCEP:ATPIII) published a 
new set of criteria that included waist circumference, 
blood lipids, blood pressure, and fasting glucose [5]. 
The previous epidemiological studies have shown 
that constitutional (obesity and smoking), hormonal, 
and musculoskeletal risk factors are associated with 
CTS and recent research indicated that MS plays an 
important role in CTS [3], [4].
The aim of the present study was to determine 
the relationship between CTS, MS, and obesity (body 
mass index [BMI] ≥30 kg/m2). Furthermore, the severity 
of CTS was compared between patients with or without 
central obesity and patients with or without MS.
Methods
Participants and data collection
All patients (n = 65) diagnosed with CTS at 
the Department of Orthopaedic Surgery in the General 
Hospital of Katerini from January 2019 to December 
2019 were included in the study. They were referred to 
the electrophysiology laboratory with sensory or motor 
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complaints in the upper limbs. The variables recorded 
were age, gender, height, weight, BMI, additional 
comorbidities (diabetes mellitus, hypertension, 
hypothyroidism, dyslipidemia, cardiovascular disease, 
nephropathy, etc.), and upper extremities trauma history 
were documented. Patients who previously received 
corticosteroid or hormone replacement treatments, 
had a history of rheumatoid arthritis or wrist fracture 
were excluded from the study. Patients conforming to 
polyneuropathy, cervical radiculopathy, and thoracic 
outlet syndrome as a result of EMG were also excluded 
from the study. The protocol was reviewed and approved 
by the Scientific Committee of the General Hospital of 
Katerini. All participants had signed the written informed 
consent.
Patients were divided into two groups 
according to the presence or the absence of MS. 
According to the NCEP ATP III definition, MS is present 
if three or more of the following five criteria are met: 
Waist circumference over 102 cm (males) or 88 cm 
(females), blood pressure over 130/85 mmHg (or taking 
anti-hypertension medication), fasting triglyceride (TG) 
level over 150 mg/dL, fasting high-density lipoprotein 
(HDL) cholesterol level less than 40 mg/dL (males) 
or 50 mg/dL (females), and fasting blood sugar over 
100 mg/dL [5]. According to the WHO, obesity is a 
medical condition, which is defined as abnormal or 
excessive fat accumulation. BMI, which is calculated 
by dividing the body weight in kilograms by height in 
meters squared (kg/m2), was used to identify obesity. A 
person with a BMI of 30 or more is generally considered 
obese [6].
Nerve conduction studies and electromyography 
were performed to resolve diagnostic uncertainty and 
to quantify and stratify disease severity. According to 
Padua’s classification [7], patients were divided into 
five groups (Table 1). For statistical convenience and 
Statistical analysis
Collected data were analyzed with SPSS 
(Version 24.0). The Kolmogorov–Smirnov test was 
utilized for normality analysis. Student’s t-test and 
Mann–Whitney U-test were utilized for the comparison of 
the quantities-continuous variables in our independent 
samples, for parametric and non-parametric distribution, 
respectively, in population divided into two categories. 
The one-way ANOVA test and the Kruskal–Wallis 
test were utilized for the comparison of the quantities-
continuous variables in our independent samples, 
for parametric and non-parametric distribution, 
respectively, in population divided into more than 2 
categories. Pearson-χ2 (cross-tabulation) was utilized 
for the comparison of the categorical variables. The 
level of significance was set at p < 0.05.
Results
Among the 65 patients included in the study, 
16 (24.6 %) were male and 49 (75.4%) were female. 
The average age was 58.91 ± 12.49 years (56.75 
± 12.28 for females and 65.5 ± 11.03 for males). 
Unilateral CTS was present in 30 (46.2%) patients, 
while 35 (53.8%) patients had bilateral CTS. Thirty-nine 
(60%) of the patients were diagnosed with MS, while 26 
(40%) did not meet the diagnostic criteria. There was a 
statistically significant difference between patients with 
and without MS and age (62.03 ± 11.57 years vs. 54.23 
± 12.56 years, p = 0.013), while there was no difference 
between the two genders (females/males: 30/9 vs. 19/7, 
p = 0.724). Bilateral CTS was present in 22 (56.4%) 
of the 39 patients with MS and in 13 (50%) of the 26 
patients without MS (p = 0.612). The CTS was described 
as mild, moderate, and severe in 8, 12, and 19 hands of 
those with MS and in 2, 6, and 18 of those without MS, 
respectively (p = 0.207) (Table 2). The proportion of 
patients who had moderate and severe CTS was higher 
Table 1: Neurophysiological classification of CTS
Grade Neurophysiological findings
Minimal CTS “Standard negative” hands with abnormal comparative or 
segmental (<7 – 8 cm) tests
Mild CTS Slowing of median digit-wrist segment and normal DML
Moderate CTS Slowing of median digit-wrist segment and abnormal DML
Severe CTS Absence of median SNAPS (digit-wrist segment) and abnormal 
DML
Extreme severe CTS Absence of thenar motor (and sensory) response
DML: Distal motor latency, SNAPS: Sensory nerve action potentials.
significance, we modified this classification into three 
groups: (a) Minimal to mild CTS (Group I); (b) moderate 
CTS (Group II); and (c) severe to extremely severe CTS 
(Group III). The patients were divided into the following 
four groups according to the presence or absence of MS 
and/or obesity: (1) Metabolic syndrome only (MS+O–), 
(2) obesity only (MS–O+), (3) metabolic syndrome and 
obesity together (MS+O+), and (4) neither metabolic 
syndrome nor obesity (MS–O–). The demographic 
characteristics, the severity of CTS according to the 
electrophysiological findings of the subjects, were 
analyzed and compared among these four groups.
Table 2: Age, gender, severity of CTS, and comorbidities in 
patients with or without MS
Variables All patients Patients with 
MS
Patients 
without MS
p-value*
Age 58.91 ± 12.49 62.02 ± 11.57 54.23 ± 12.56 0.013
Gender (F/M, n) 16/49, 65 9/30, 39 7/19, 26 0.724
Bilateral CTS (n, %) 35 (53.8%) 22 (56.4%) 13 (50%) 0.612
Severity of CTS
Mild (n, %) 10 (15.4%) 8 (20.5%) 2 (7.7%) 0.207
Moderate (n, %) 18 (27.7%) 12 (30.8%) 6 (23.1%)
Severe (n, %) 37 (56.9%) 19 (48.7%) 18 (69.2%)
Comorbidities
Hypertension (n, %) 34 (52.3%) 28 (71.8%) 6 (23.1%) < 0.001
Dyslipidemia (n, %) 17 (26.6%) 17 (43.6%) < 0.001
Hypothyroidism (n, %) 10 (15.4%) 5 (12.8%) 5 (19.2%) 0.483
DM (n, %) 7 (10.8%) 6 (15.4%) 1 (3.8%) 0.142
CVD (n, %) 7 (10.8%) 5 (12.8%) 2 (7.7%) 0.513
GERD (n, %) 3 (4.6%) 3 (11.5%) 0.030
BPH (n, %) 1 (1.5%) 1 (2.6%) 0.411
Anemia (n, %) 1 (1.5%) 1 (3.8%) 0.217
Nephropathy (n, %) 1 (1.5%) 1 (3.8%) 0.217
Except where indicated otherwise, the data are mean ± SD. *The threshold for statistical significance was p 
< 0.05. CTS: Carpal tunnel syndrome, MS: Metabolic syndrome, F: Female, M: Male, DM: Diabetes mellitus, 
CVD: Cardiovascular disease, BPH: Benign prostate hyperplasia, GERD: Gastroesophageal reflux disease.
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in those with MS than in those without (p = 0.160). A 
majority (69.2%) of patients, with or without MS, had at 
least one comorbidity, with hypertension being the most 
common 1 (52.3%), followed by dyslipidemia (26.6%), 
hypothyroidism (15.4%), diabetes mellitus (10.8%), and 
cardiovascular disease (10.8%) (Table 2).
Based on the BMI, there were 7 patients (10.8%) 
with normal weight (BMI: less than 25), 31 patients (47.7%) 
were overweight (BMI: 25–29.9), and 27 patients (41.5%) 
were obese (BMI: 30 and higher). In the first category, 
there was one patient with mild CTS, one patient with 
moderate CTS, and five patients with severe CTS. In the 
overweight category, there were 6 patients with mild CTS, 
9 patients with moderate CTS, and 16 patients with severe 
CTS. In the patients with BMI of 30 and higher, there 
were 3 patients with mild CTS, 8 patients with moderate 
CTS, and 16 patients with severe CTS. There were no 
statistically significant difference observed between BMI 
and the severity of CTS (p > 0.05) (Figure 1).
Figure 1: Stratification of body mass index based on the severity of 
carpal tunnel syndrome
Stratification of the patients according to the 
presence/absence of MS/obesity yielded the following 
CTS patient distribution: MS+O–, n = 4; MS–O+, n = 14; 
MS+O+, n = 35; and MS–O–, n = 12. Comparison of 
the electrophysiological findings of these four patient 
groups revealed that the severity of CTS was worse in 
MS–O+ patients than in MS+O– patients (p = 0.369). The 
severity of CTS was worse in MS+O+ patients than in 
MS+O–, MS–O+, and MS–O– patients (p = 0.265). The 
electrophysiological findings in the four groups and the 
relationships between them are listed in Table 3.
Table 3: Severity of carpal tunnel syndrome according to the 
presence/absence of metabolic syndrome and/or obesity
Group Mild, n (%) Moderate, n (%) Severe, n (%) p value*
MS+O– 1 (25) 2 (50) 1 (25) 0.510
MS–O+ 2 (14.3) 3 (21.4) 9 (64.3)
MS+O+ 7 (20) 10 (28.6) 18 (51.4)
MS–O– 0 (0) 3 (25) 9 (75)
*The threshold for statistical significance was p < 0.05. MS+O–: CTS patients with metabolic syndrome only, 
MS–O+: CTS patients with obesity only, MS+O+: CTS patients with both metabolic syndrome and obesity, 
MS–O–: CTS patients with neither metabolic syndrome nor obesity; MS: Metabolic syndrome, O: Obesity.
The occurrence of abdominal obesity, 
hypertension, hyperglycemia, and dyslipidemia 
(hypertriglyceridemia, high serum LDL, low serum HDL, 
and high serum cholesterol) was compared among the 
four groups (Table 4). The waist circumferences in the 
MS+O–, MS–O+, MS+O+, and MS–O– groups were 94.75 
± 7.36, 98.79 ± 9.64, 106.42 ± 10.78, and 86.41 ± 6.78 
cm, respectively (p < 0.001) (Table 4). The mean waist 
circumference of the MS+O– group was lower than in the 
MS–O+ group (p = 0.670) and MS+O+ group (p = 0.015). 
The frequencies of hypertension in the MS+O–, MS–O+, 
MS+O+, and MS–O– groups were 100%, 35.7%, 91.4%, 
and 66.7%, respectively (p = 0.123). The frequency 
of hypertension was lower in the MS–O+ group than in 
the other three groups (p < 0.001). The frequencies of 
dyslipidemia in the MS+O– and MS+O+ groups were 75% 
and 40%, respectively (p = 0.001). The frequencies of 
diabetes mellitus in the MS+O+ and MS–O– groups were 
17.1% and 8.3%, respectively (p < 0.001).
Discussion
Carpal tunnel syndrome is the most common 
entrapment neuropathy with a prevalence of 2.7–5.8 
in the general population [1], [8]. Clinical studies have 
shown that MS was found to be approximately 3 times 
more common in patients with CTS, while CTS was 
found to be more severe in patients with MS [9], [10]. 
A possible reason why CTS is more common in MS is 
that MS is a condition driven by inflammation with a 
variety of biomarkers and cell types are emerged as 
significant mediators of this inflammation. Mast cells in 
subcutaneous adipose tissue seem to play a crucial role 
Table 4: Body mass index, presence of hypertension, dyslipidemia, hyperglycemia, and waist circumference in the carpal tunnel 
syndrome patients stratified according to the presence/absence of metabolic syndrome and/or obesity
Variables MS+O– MS–O+ MS+O+ MS–O– p-value*
BMI (kg/m2) 26.4 ± 1.28 29.17 ± 2.7 32.24 ± 5.39 24.92 ± 2.78 < 0.001
SBP (mmHg) 148.75 ± 17.42 132.78 ± 19.53 145.42 ± 15.5 139.5 ± 20.89 0.123
DBP (mmHg) 87.75 ± 14.75 82.28 ± 12.07 87.68 ± 11.59 87.66 ± 10.78 0.366
TG (mg/dL) 175.25 ± 38.9 106.64 ± 40.53 145.14 ± 51.85 93.08 ± 25.6 0.001
HDL (mg/dL) 42.15 ± 6.51 63.57 ± 13.36 56.05 ± 19.5 63.1 ± 17.45 0.017
LDL (mg/dL) 125.3 ± 36.52 134.56 ± 18.32 110.47 ± 31.85 109.19 ± 25.62 0.045
Cholesterone (mg/dL) 202.5 ± 42.58 219.42 ± 26.34 198.28 ± 36.54 190.75 ± 37.34 0.179
Glucose (mg/dL) 129 ± 14.25 91.6 ± 8.76 123.57 ± 45.11 106.66 ± 36.01 < 0.001
Waist circumference (cm) 94.75 ± 7.36 98.78 ± 9.64 106.42 ± 10.78 86.41 ± 6.77 < 0.001
*The threshold for statistical significance was p < 0.05. MS+O–: CTS patients with metabolic syndrome only, MS–O+: CTS patients with obesity only, MS+O+: CTS patients with both metabolic syndrome and obesity, 
MS–O–: CTS patients with neither metabolic syndrome nor obesity, MS: Metabolic syndrome, O: Obesity, BMI: Body mass index, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, TG: Triglyceride, HDL: 
High-density lipoprotein, LDL: Low-density lipoprotein.
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in promotion both of inflammation and fibrosis around 
and within the median nerve resulting in the inhibition of 
nerve gliding [5], [9], [11].
The present study analyzed the impact of MS 
and obesity on the severity of CTS and evaluated the 
association between MS with or without obese people 
and CTS. The rate of MS in patients with CTS has been 
found to be between 48% and 75% in the previous 
studies [9], [10]. These reported different prevalence 
rates of MS in the patients with CTS may be the result of 
genetic factors, environmental/occupational conditions, 
the different age of the studied populations, and the 
lifestyle of the populations concerned. In agreement 
with these findings [9], [10], in the present study, MS 
was also found in 60% of patients with CTS with a 
mean age of 62.03 ± 11.57 years. CTS was also more 
severe in the patients with MS than in those without. 
Nowadays, MS is a major public health problem and 
is characterized by abdominal obesity, hypertension, 
dyslipidemia, and hyperglycemia [5].
Female patients and patients aged between 
40 and 60 years are more likely to develop CTS. One 
study involved 107 patients with CTS (mean age 53.9 ± 
8.9), of whom 89.7% were female [10]. Yurdakul et al. 
included 200 patients with CTS (mean age 51.61 
± 11.86), of whom 140 (70%) were female [9]. In a 
descriptive cross-sectional study of 112 patients with 
a mean age of 54 ± 5 years, 65% were female [11]. 
Similar to these findings, 49 (75.4%) of the patients in 
the present study were female.
Previously, Werner et al. reported that only 
16% of individuals with a BMI below 20 kg/m2 had CTS 
compared with 39% of individuals with BMI of 29 kg/
m2 and higher [12]. They reported that CTS patients are 
2 times more likely to be obese than slender ones and 
female patients are 2 times more likely to be obese. 
Nordstrom et al. demonstrated that a weight gain of 
about six pounds increased the risk of developing CTS 
by 8% [13]. This trend was also observed in the patients 
of the present study, while 42.5% of the patients had a 
BMI of ≥30 kg/m2. Female patients were also 3 times 
more likely to be obese than male patients. We also 
identified a relationship between severity of CTS and 
obese population, with the highest BMI in patients with 
severe CTS. In another study by Kouyoumdjian et al., 
they studied the influence of higher BMI in the severity 
of CTS and found that CTS had a significant correlation 
with higher BMI when compared to control subjects [14].
Hyperglycemia, obesity, and dyslipidemia, 
which are the components of MS, have been proposed 
as possible risk factors for CTS [3]. In the present study, 
comparisons between patients with or without MS and 
obesity revealed significantly higher waist circumference 
in patients with MS+O+. Moreover, lipid profile including 
HDL and serum TG was significantly different in 
those with MS+O– compared to those with MS–O+. 
Hyperglycemia was significantly higher in patients with 
MS+O– compared to MS–O+ patients. El Gharieb et al. 
recruited 103 female patients of CTS with a mean age 
between 31 and 42 years (according to the severity 
of CTS) and found mean triglycerides levels 159.02 ± 
53.7 mg/dL, mean LDL cholesterol levels 140.45 ± 
47.74 mg/dL, and mean HDL cholesterol levels 54.34 ± 
8.62 mg/dL [15]. In the present study, the patients’ mean 
triglycerides levels were elevated 175.25 ± 38.9 mg/dL 
and their mean LDL/HDL cholesterol levels were lower 
125.3 ± 36.52/56.05 ± 19.5 mg/dL. These differences 
could be due to differences in ethnicity, geographic 
distribution, dietary habits, and/or lifestyle modifications.
In the current study, a significant association 
was detected between hypertension, dyslipidemia, and 
cardiovascular diseases and the development of CTS. 
High percentages of patients with CTS had one or more 
of these diseases. These findings might be explained 
by the reported high rates of CTS among the studied 
population. In accordance with this, Alotaibi et al. 
reported higher incidence (36.4%) of hypertension in 
CTS patients compared to control group [16]. In addition, 
Sharief et al. demonstrated hypertension in 25% and 
dyslipidemia 24% of patients who were diagnosed with 
CTS [17]. Küçükakkas and Yurdakul demonstrated that 
among patients with CTS, 14% had hypertension [18].
The present study has some limitations. First, 
this was a public hospital-based study conducted on 
patients of specific socioeconomic status having a 
different clinical and risk factor profile, so these results 
cannot be applied to the general population. Second, 
the number of cases is small, thus the need of more 
studies with larger samples is needed to confirm and 
improve precision of the results.
Conclusion
Despite the small number of included patients 
with CTS, the results of the present study suggest that 
CTS appears to be more severe in patients with MS 
than patients with obesity. Central obesity is one of 
the well-known risk factors for CTS, but components 
of MS may have a greater effect on the severity of 
CTS. However, further research with larger samples is 
needed to enforce these results.
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